Trusted medical support in China for Mongolian patients
Cross-border care assistance · Standard service
China–Mongolia cross-border medical consultation is available. Contact us by phone or Facebook.Partner of the Third Central Hospital of Mongolia
Back to doctors
Le Yun Yi
Associate Chief Physician

Peking University Third Hospital · Endocrinology Department · Beijing

2014, 、 、. 、 、, 、 、 、,,,. 、 、 、 、 (1) Chen C; Meng S; Wu X; Ciren W; Shen J; Zeding Z; Yang L; Tian Q; Lv X; Le Y. Vitamin D deficiency and the risk of diabetic retinopathy in patients with type 2 diabetes in Tibet: a cross-sectional analysis. BMC Endocr Disord, 2024, 24(1):139. (2) Le Y, Zhang J, Hong T, Yang J. Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report. J Diabetes Investig. 2024,15(7):964-967. (3) Le Y; Yang J; Li F; Jiang Y; Wei T; Wang D; Wang K; Cui X; Lin X; Yang K; Hong T; Wei R; Dapagliflozin improves pancreatic islet function by attenuating microvascular endothelial dysfunction in type 2 diabetes, Diabetes Metab Res Rev, 2023, 39(3): e3607. (4) Zhao X; Li L; Guo X; Wang J; Yan Y; Le Y; Potentially Inappropriate Medication Use AmongOlder Patients with Diabetes in a Chinese Community, Exp Clin Endocrinol Diabetes, 2023, 131(10):548-553. (5) Le Y; Yang K; Yang J; Fu W; Xiao W; Wei R; Hong T; Association of Time in Range with Endothelial Injury in Patients with Type 2 Diabetes Treated with Exenatide, Diabetes Ther, 2022,13(10): 1755-1767. ( 6 ) Yang J, Le Y, Wei T, Wang K, Yang K, Xiao W, Hong T, Wei R. Non-targeted metabolomic analysis predicts the therapeutic effects of exenatide on endothelial injury in patients with type 2 diabetes. J Diabetes Complications. 2021, 35(2):107797. ( 7 ) Le Y; Wei R; Yang K; Lang S; Gu L; Liu J; Hong T; Yang J; Liraglutide ameliorates palmitate-induced oxidative injury in islet microvascular endothelial cells through GLP-1receptor/PKA and GTPCH1/eNOS signaling pathways, Peptides, 2020, 124: 170212. (8),,,. [J].,2020,28(10):779-782. DOI:10.3969/j.issn.1006⁃6187.2020.10.012. (9),,. β [J].,2019,99(34):2650-2653. DOI:10.3760/cma.j.issn.0376-2491.2019.34.003. (10),,,. [J].,2019,11(12):821-824. DOI:10.3760/cma.j.issn.1674-5809.2019.12.011. (11),,. - - [J].,2017,9(12):784-786. DOI:10.3760/cma.j.issn.1674-5809.2017.12.012. 《 —— 》、《 》

Remove this favorite?